A systematic, platform-agnostic search is needed to get new and improved COVID-19 vaccines that provide longer and broader immunity, US Food and Drug Administration’s Peter Marks urged in recent New England Journal of Medicine interview.
More work needs to be done to “keep ahead of the virus,” the Center for Biologics Evaluation and Research Director said in the interview, citing concerns SARS-CoV-2 might eventually mutate in such a way that
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?